Cellosaurus logo
expasy logo

Cellosaurus SV-BR-1 (CVCL_4U12)

[Text version]
Cell line name SV-BR-1
Synonyms SV-BR1
Accession CVCL_4U12
Resource Identification Initiative To cite this cell line use: SV-BR-1 (RRID:CVCL_4U12)
Comments Group: Patented cell line.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7812.
Characteristics: ER/PR-negative and ERBB2-positive.
Doubling time: 48 hours (Patent=US7674456).
Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
Disease Breast carcinoma (NCIt: C4872)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_4U13 (SV-BR-1-GM)
Sex of cell Female
Age at sampling 39Y
Category Cancer cell line
Publications

PubMed=16958969; DOI=10.1111/j.1075-122X.2006.00319.x
Wiseman C.L., Kharazi A.
Objective clinical regression of metastatic breast cancer in disparate sites after use of whole-cell vaccine genetically modified to release sargramostim.
Breast J. 12:475-480(2006)

Patent=US7674456
Wiseman C.L., Kharazi A.
Breast cancer cell lines and uses thereof.
Patent number US7674456, 09-Mar-2010

Cross-references
Cell line collections (Providers) ATCC; PTA-7812
Encyclopedic resources Wikidata; Q54970928
Entry history
Entry creation22-Sep-2015
Last entry update29-Jun-2023
Version number7